Concepedia

Publication | Open Access

Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial

DOIFull Paper Access

69

Citations

18

References

2018

Year

Michail Ignatiadis, Saskia Litière, Françoise Rothé, Sabine Riethdorf, Charlotte Proudhon, Tanja Fehm, K.C. Aalders, Helmut Forstbauer, Peter A. Fasching, Étienne Brain,
Annals of Oncology

Abstract

Trastuzumab does not decrease the detection rate of CTCs in HER2 nonamplified, nonmetastatic breast cancer.

References

YearCitations

Page 1